| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/05/1995 | WO1995000649A1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/05/1995 | WO1995000646A1 Interleukin-3 (il-3) human/murine hybrid polypeptides |
| 01/05/1995 | WO1995000643A2 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | WO1995000642A1 Vertebrate apoptosis gene: compositions and methods |
| 01/05/1995 | WO1995000641A1 Lipopolysaccharide binding protein derivatives |
| 01/05/1995 | WO1995000636A1 A fungal protein disulfide isomerase |
| 01/05/1995 | WO1995000633A2 Construction and use of synthetic constructs encoding syndecan |
| 01/05/1995 | WO1995000553A1 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 01/05/1995 | WO1995000551A1 Prostaglandin receptor fp and dna encoding it |
| 01/05/1995 | WO1995000550A1 Aspb28 insulin crystals |
| 01/05/1995 | WO1995000549A1 Treatment of diabetes using phosphorylated insulin |
| 01/05/1995 | WO1995000548A1 Biologically active vasopressin analogues |
| 01/05/1995 | WO1995000547A1 Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type |
| 01/05/1995 | WO1995000546A1 Endothelin-antagonizing peptide |
| 01/05/1995 | WO1995000544A1 Method and composition for treating thrombosis |
| 01/05/1995 | WO1995000543A1 Anti-inflammatory peptides |
| 01/05/1995 | WO1995000542A1 Bombesin receptor antagonists and uses thereof |
| 01/05/1995 | WO1995000541A1 Factor vii-derived peptides |
| 01/05/1995 | WO1995000538A1 Peptides derived from human interleukin-2 for use in medicine |
| 01/05/1995 | WO1995000537A1 New compound and its preparation |
| 01/05/1995 | WO1995000536A1 Peptide compounds |
| 01/05/1995 | WO1995000535A1 Optically pure calpain inhibitor compounds |
| 01/05/1995 | WO1995000527A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | WO1995000477A1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system |
| 01/05/1995 | WO1995000474A1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES |
| 01/05/1995 | WO1995000178A1 Pore-forming and superantigen encoding toxin cassettes for gene therapy |
| 01/05/1995 | WO1995000171A1 A stabilised phenylalanine ammonia lyase |
| 01/05/1995 | WO1995000170A1 Inhibition of human immunodeficiency virus reproduction by deoxyribonuclease i |
| 01/05/1995 | WO1995000169A1 Medical use of stem bromelain protease |
| 01/05/1995 | WO1995000168A1 Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |
| 01/05/1995 | WO1995000167A1 Use of human growth hormone for preoperative administration |
| 01/05/1995 | WO1995000166A1 Pharmaceutical compositions for stimulating reconstruction of hemopoietic microenvironment |
| 01/05/1995 | WO1995000165A1 Selectively cleavable linkers based on iminodiacetic acid ester bonds |
| 01/05/1995 | WO1995000164A1 PEPTIDES AND ANTIBODIES TO HUMAN C5a RECEPTOR AND METHOD OF TREATMENT |
| 01/05/1995 | WO1995000163A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/05/1995 | WO1995000161A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | WO1995000160A1 Programmed cell death genes and proteins |
| 01/05/1995 | WO1995000159A1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 01/05/1995 | WO1995000156A1 Compositions and methods for treatment and prevention of retinal dysfunctions |
| 01/05/1995 | WO1995000151A1 Absorption enhancers for drug administration |
| 01/05/1995 | WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | WO1995000135A1 Medical treatment using thyroid hormones |
| 01/05/1995 | WO1995000128A1 Compositions for inhalation |
| 01/05/1995 | WO1995000127A1 Therapeutic preparation for inhalation |
| 01/05/1995 | WO1995000121A1 Compressible enzyme powder |
| 01/05/1995 | WO1995000115A1 Utilization of a peptide having a lysin group and an alanine group in the terminal position for the preparation of a depigmenting composition, and depigmenting composition thus obtained |
| 01/05/1995 | WO1994024164A3 Human monoclonal antibodies and processes and materials for making such antibodies |
| 01/05/1995 | WO1994024160A3 Erythropoietin muteins with enhanced activity |
| 01/05/1995 | WO1994023041A3 Method for selective inactivation of viral replication |
| 01/05/1995 | WO1994021792A3 Inhibition of selected tumor growth with recombinant viral vectors |
| 01/05/1995 | WO1994018324A3 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
| 01/05/1995 | WO1994017099A3 BIOLOGICALLY ACTIVE TGF-β1 AND TGF-β2 PEPTIDES |
| 01/05/1995 | DE4320822A1 Pharmaceutical composition with a novel type of action |
| 01/05/1995 | CA2165951A1 Treatment of diabetes using phosphorylated insulin |
| 01/05/1995 | CA2165822A1 The medical treatment using thyroid hormones |
| 01/05/1995 | CA2165797A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
| 01/05/1995 | CA2165790A1 New compound and its preparation |
| 01/05/1995 | CA2165787A1 Medical use of stem bromelain protease |
| 01/05/1995 | CA2165786A1 Methods of isolating cd1-presented antigens, vaccines comprising cd1-presented antigens, and cell lines for use in said methods |
| 01/05/1995 | CA2165777A1 Programmed cell death genes and proteins |
| 01/05/1995 | CA2165679A1 Anti-sickling hemoglobin |
| 01/05/1995 | CA2165559A1 Human cell adhesion protein aamp-1 and uses thereof |
| 01/05/1995 | CA2165469A1 Methods of making amino acids useful in preparing gnrh analogs |
| 01/05/1995 | CA2165332A1 Method and composition for treating thrombosis |
| 01/05/1995 | CA2165284A1 Compressible enzyme powder |
| 01/05/1995 | CA2165281A1 A stabilised phenylalanine ammmonia lyase |
| 01/05/1995 | CA2165200A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2164966A1 Compositions and methods for anti-addictive narcotic analgesis activity screening and treatments |
| 01/05/1995 | CA2164961A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 01/05/1995 | CA2164955A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | CA2164424A1 Mesothelial cell gene therapy |
| 01/05/1995 | CA2164422A1 Factor vii-derived peptides |
| 01/05/1995 | CA2163453A1 Use of human growth hormone for preoperative administration |
| 01/05/1995 | CA2163352A1 Biologically active vasopressin analogues |
| 01/05/1995 | CA2142985A1 Endothelin-antagonizing peptide |
| 01/04/1995 | EP0632129A1 Recombinant foamy virus vectors for medicinal and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 01/04/1995 | EP0632055A1 An anticoagulant substance obtained from urine |
| 01/04/1995 | EP0632053A2 Cyclic adhesion inhibitors |
| 01/04/1995 | EP0632052A1 Endothelin antagonistic peptides |
| 01/04/1995 | EP0632051A1 Anti-picornaviral agents |
| 01/04/1995 | EP0631786A1 Lys - plasminogen in the prevention and treatment of ischemia and reperfusian injury |
| 01/04/1995 | EP0631727A1 Lipase inhibitor derived from a defatted rice germ |
| 01/04/1995 | EP0631624A1 Receptor complexes with b29 (ig-beta or ig-gamma) and their uses |
| 01/04/1995 | EP0631623A1 Dna encoding taurine and gaba transporters and uses thereof |
| 01/04/1995 | EP0631619A1 Reconstituted cartilage tissue |
| 01/04/1995 | EP0631617A1 Colon crypt cell mitogen, cell line producing it, and uses thereof |
| 01/04/1995 | EP0631586A1 Amino procollagen 1(i) peptides |
| 01/04/1995 | EP0631584A1 Cancer diagnosis and therapy |
| 01/04/1995 | EP0631570A1 Compounds |
| 01/04/1995 | EP0631507A1 Selective alteration of antibody immunogenicity |
| 01/04/1995 | EP0631505A1 Use of a peptide |
| 01/04/1995 | EP0631504A1 Novel medicament |
| 01/04/1995 | EP0631503A1 Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 01/04/1995 | EP0631502A1 Lymphocyte activity regulation by hla peptides |
| 01/04/1995 | EP0631501A1 Glycosylation-mediated inhibition of factor x |
| 01/04/1995 | EP0567576B1 Treatment of neoplastic disease with interleukin-10 |
| 01/04/1995 | EP0514405B1 Strain ral-4, useful for production of small proteins and peptides |
| 01/04/1995 | EP0463072B1 Novel insulin compounds |
| 01/04/1995 | EP0435946B1 Methods for modifying the binding of cell adhesion receptors |
| 01/04/1995 | CN1096962A Dynorphin a suppression of natural killer cell activity |